Search Results 2491-2500 of 17806 for rheumatoid arthritis

  1. Study Of SX-682 Alone And In Combination With Oral Or Intravenous Decitabine In Subjects With Myelodysplastic Syndrome - Mayo Clinic

    * Use of erythroid stimulating agents, Granulocyte-colony stimulating factor (G-CSF), or Granulocyte-macrophage colony-stimulating factor (GM-CSF) within 14 ...

  2. Efficacy and Safety of Seralutinib in Adult Subjects With PAH - Mayo Clinic

    Tyrosine kinase inhibitors, other than Janus kinase inhibitors approved for systemic autoimmune rheumatic diseases, within 12 weeks prior to Screening. 2 ...

  3. Back Pain Clinical Trials - Mayo Clinic Research

    Spinal cord stimulation (SCS) has been used for almost 30 years to treat many intractable back pain conditions. It has demonstrated efficacy in the co-called ...

  4. Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors - Mayo Clinic

    No prior treatment with an inhibitor of vascular endothelial growth factor (VEGF) or vascular endothelial growth factor receptor (VEGFR); Prior treatment ...

  5. Publications - Sher-Lu Pai, M.D. - Mayo Clinic

    ... Factor Analysis From 7 Academic Centers in the United States. Anesth Analg. 2021 Jan; 132 (1):130-139. View PubMed; Porter SB, Hughes AJ, Ball CT, Hex KO ...

  6. Sarcoma - Doctors and departments - Mayo Clinic

    ... arthritis, Basilar skull invagination, Neurofibromatosis type 2, Pancoast tumor, Failed back syndrome, Nerve irritation, Brachial plexus avulsion pain ...

  7. Chemotherapy For Clinical Trials - Mayo Clinic Research

    ... Factor Receptor 2, also known as HER2-positive breast cancer. The drug involved in this study is: -ado-trastuzumab emtansine (T-DM1). Study of Trastuzumab ...

  8. Deb Balzer | Mayo Clinic News Network - Page 52 of 72

    Besides the ick factor, Dr. Dawn Davis, a dermatologist at Mayo Clinic, says sharing your lip balm or lip moisturizer with another person is a bad idea ...

  9. Publications - Deb A. Baumgarten, M.D., M.P.H. - Mayo Clinic

    Ramucirumab and Docetaxel in Patients with Metastatic Urothelial Carcinoma Harboring Fibroblast Growth Factor Receptor Alterations: A Case Series and Literature ...

  10. Publications - Benjamin M. Howe, M.D. - Mayo Clinic

    ... arthritis. Emerg Radiol. 2024 Aug; 31 (4):491-497 Epub 2024 June 07. View PubMed; Maldonado AA, Marek T, Howe BM, Broski SM, Carter JM, Spinner RJ ...